Long-Term Patency Rates of Portal Vein/Superior Mesenteric Vein Reconstruction after Pancreatic Resection for Pancreatic Tumors: Single-Center Experience
View abstract on PubMed
Summary
This summary is machine-generated.Pancreatic surgery often requires portal vein resection. This study found a high 90.2% patency rate for venous reconstruction at one year, indicating good long-term outcomes for patients undergoing pancreatic cancer surgery.
Area Of Science
- Surgical Oncology
- Vascular Surgery
- Gastroenterology
Background
- Achieving R0 resection in pancreatic ductal adenocarcinoma necessitates portal/superior mesenteric vein resection.
- Optimal reconstruction techniques for these resected veins remain undefined, impacting patient outcomes.
Purpose Of The Study
- To evaluate the long-term patency of portal/superior mesenteric vein reconstructions after pancreatic resection.
- To identify predictors of postoperative venous thrombosis or stenosis following pancreatic surgery.
Main Methods
- Retrospective cohort analysis of 53 patients undergoing pancreatic resection with venous resection.
- Vascular reconstruction methods included primary closure, end-to-end anastomosis, and interposition grafts.
- Computed tomographic imaging assessed vein patency at 3, 6, 9, and 12 months post-surgery.
Main Results
- 90.2% of patients demonstrated fully patent venous reconstructions at the 1-year follow-up.
- No significant perioperative or postoperative factors were associated with increased reconstruction thrombosis risk.
- Reconstruction types: 26.4% primary closure, 22.7% end-to-end anastomosis, 50.9% interposition graft.
Conclusions
- High long-term patency rates (90.2% at 1 year) support current venous reconstruction practices in pancreatic surgery.
- Further randomized controlled trials are needed to establish the optimal venous reconstruction method.

